a Journal of Postdoctoral Research and Postdoctoral Affairs.
    ISSN : 2328-9791
left right
GSH inhalation therapies in CF: how useful, how safe? Set-up of a CF murine model for monitoring of inflammation in vivo and assessment of convenient alternatives
Author(s) : Corti A, Melotti P, Sorio C, Bergamini G, Hector A, Griese M, Pompella A
Address : University of Pisa, University of Verona, University of Tübingen Children's Hospital, Ludwig-Maximilians-University Munich
Multiple Institutions in collaboration

Background. Inhalation treatments with glutathione (GSH) have gained interest among CF patients. GSH is a primary antioxidant whose levels are significantly decreased in lungs during inflammatory processes. However the results attained so far remain disappointing. One of the possible reasons may lie in the fact that CF lungs often present with increased levels of gammaglutamyltransferase (GGT), an enzyme secreted by inflammatory cells, capable of degrading GSH.

Hypothesis and objectives. The hypothesis to be verified was whether the different levels of airways GGT in CF patients might modulate the effects of GSH-based therapies. It is of importance to clarify whether GSH inhalation therapies are truly beneficial, useless or even – in selected conditions – potentially dangerous. 


home phone mail info@postdocjournal.com
twitter facebook social icon Social link You Tube sky
Click Here